Home / Fact sheets / Republic of Korea / Cervical quantitative data
Country fact sheet: Republic of Korea (Index year: )
Age group | 20-24 | 25-29 | 30-34 | 35-39 | 40-44 | 45-49 | 50-54 | 55-59 | 60-64 | 65-69 | 70-74 | 75-79 | Age unknown | Total |
Interval | ||||||||||||||
Screening interval (months) | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | ||||
Population (personally invited) | ||||||||||||||
Target population | 1903560 | 1193998 | 2066798 | 1534336 | 2404434 | 1848784 | 2441884 | 1737586 | 1860652 | 919854 | 17 911 886 | |||
Annual target population | 951 780 | 596 999 | 1 033 399 | 767 168 | 1 202 217 | 924 392 | 1 220 942 | 868 793 | 930 326 | 459 927 | 0 | 0 | 0 | 8 955 943 |
Women invited | 951780 | 596999 | 1033399 | 767168 | 1202217 | 924392 | 1220942 | 868793 | 930326 | 459927 | 8 955 943 | |||
Invitation coverage (%) | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 0.0 | 0.0 | 0.0 | 100.0 |
Examinations (All tests in the year) | ||||||||||||||
Women screened | 142 672 | 197 825 | 469 843 | 366 755 | 657 084 | 499 054 | 651 682 | 487 543 | 520 266 | 251 842 | 0 | 0 | 0 | 4 244 566 |
Examination coverage rate (%) | 15.0 | 33.1 | 45.5 | 47.8 | 54.7 | 54.0 | 53.4 | 56.1 | 55.9 | 54.8 | 0.0 | 0.0 | 0.0 | 47.4 |
Result (All tests in the year) | ||||||||||||||
Positive | 6 943 | 7 915 | 14 746 | 10 468 | 18 338 | 14 995 | 17 679 | 10 481 | 9 457 | 4 491 | 0 | 0 | 0 | 115 513 |
Negative | 135 729 | 189 910 | 455 097 | 356 287 | 638 746 | 484 059 | 634 003 | 477 062 | 510 809 | 247 351 | 0 | 0 | 0 | 4 129 053 |
Unknown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Referral for further assessment (%) | 4.9 | 4.0 | 3.1 | 2.9 | 2.8 | 3.0 | 2.7 | 2.1 | 1.8 | 1.8 | 0.0 | 0.0 | 0.0 | 0.0 |
Further assessment (all positive) | ||||||||||||||
Done | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Not done | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unknown | 6 943 | 7 915 | 14 746 | 10 468 | 18 338 | 14 995 | 17 679 | 10 481 | 9 457 | 4 491 | 0 | 0 | 0 | 115 513 |
Further assessment participation rate (%) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Outcome (CIN 1, CIN 2 and CIN 3 separetely) | ||||||||||||||
No biopsy performed, no CIN nor ca detected | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No biopsy performed, treated on the basis of colpo diagnosis of CIN (see and treat) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unsatisfactory histology | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Carcinoma | 4 | 21 | 109 | 118 | 210 | 178 | 203 | 140 | 133 | 91 | 0 | 0 | 0 | 1 207 |
CIN3 / Adenocarcinoma in situ (CGIN) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CIN2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CIN1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other histology | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unknown | -4 | -21 | -109 | -118 | -210 | -178 | -203 | -140 | -133 | -91 | 0 | 0 | 0 | -1 207 |